Inhibition of cruzipain, the major cysteine proteinase of the protozoan parasite, Trypanosoma cruzi, by proteinase inhibitors of the cystatin superfamily

Cruzipain, the major cysteine proteinase from Trypanosoma cruzi epimastigotes, purified to a sequentially pure form, exists in multiple forms with pI values between 3.7 and 5.1, and an apparent molecular mass of 41 kDa. The enzyme is stable between pH 4.5-9.5. Cruzipain was found to be rapidly and t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Stoka, V.
Otros Autores: Nycander, M., Lenarčič, B., Labriola, C., Cazzulo, J.J, Björk, I., Turk, V.
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 1995
Materias:
PH
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 08725caa a22012977a 4500
001 PAPER-12444
003 AR-BaUEN
005 20230518204238.0
008 190411s1995 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-0029161123 
024 7 |2 cas  |a cystatin, 81989-95-9; cysteine proteinase, 37353-41-6; proteinase inhibitor, 37205-61-1; stefin A, 107544-29-6; stefin B, 106178-19-2; cruzipain, EC 3.4.22.-; Cystatins; Cysteine Endopeptidases, EC 3.4.22; Recombinant Proteins; stefin A, 107544-29-6 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a FEBLA 
100 1 |a Stoka, V. 
245 1 0 |a Inhibition of cruzipain, the major cysteine proteinase of the protozoan parasite, Trypanosoma cruzi, by proteinase inhibitors of the cystatin superfamily 
260 |c 1995 
270 1 0 |m Stoka, V.; Department of Biochemistry and Molecular Biology, J. Stefan Institute, Jamova 39, 61111 Ljubljana, Slovenia 
506 |2 openaire  |e Política editorial 
504 |a Brocklehurst, Willenbrock, Salih, (1987) Hydrolytic enzymes, pp. 39-155. , A. neuberger, K. Brocklehurst, Elsevier, Amsterdam 
504 |a Cazzulo, Frasch, (1992) FASEB J., 6, pp. 3259-3264 
504 |a Cazzulo, Hellman, Couso, Parodi, (1990) Mol. Biochem. Parasitol., 38, pp. 41-48 
504 |a Campetella, Martínez, Cazzulo, (1990) FEMS Microbiol. Lett., 67, pp. 145-150 
504 |a Bontempi, Martínez, Cazzulo, (1989) Mol. Biochem. Parasitol., 33, pp. 43-48 
504 |a Martínez, Campetella, Frasch, Cazzulo, (1991) Infect. Immun., 59, pp. 4275-4277 
504 |a Bontempi, Cazzulo, (1990) FEMS Microbiol. Lett., 70, pp. 337-342 
504 |a Souto-Padrón, Campetella, Cazzulo, Souza, Cysteine proteinase in Trypanosoma cruzi: immunocytochemical localization and involvement in parasite-host cell interaction. (1990) J Cell Sci, 96, pp. 485-490 
504 |a Franke de Cazzulo, Martínez, North, Coombs, Cazzulo, (1994) FEMS Microbiol. Lett., 124, pp. 81-86 
504 |a Cazzulo, Couso, Raimondi, Wernstedt, Hellman, (1989) Mol. Biochem. Parasitol., 33, pp. 33-42 
504 |a Cazzulo, Cazzulo Franke, Martínez, Franke de Cazzulo, (1990) Biochim. Biophys. Acta, 1037, pp. 186-191 
504 |a Labriola, Sousa, Cazzulo, (1993) Biol. Res, 26, pp. 101-107 
504 |a Berti, Storer, (1995) J. Mol. Biol., 246, pp. 273-283 
504 |a Cazzulo, Martínez, Parodi, Wernstedt, Hellman, (1992) FEMS Microbiol. Lett., 100, pp. 411-416 
504 |a Hellman, Wernstedt, Cazzulo, (1991) Mol. Biochem. Parasitol., 44, pp. 15-22 
504 |a Campetella, Henriksson, Aslund, Frasch, Petterson, Cazzulo, (1992) Mol. Biochem. Parasitol., 50, pp. 225-234 
504 |a Eakin, McGrath, McKerrow, Fletterick, Craick, (1993) J. Biol. Chem., 268, pp. 6115-6118 
504 |a McGrath, Engel, McKerrow, Craick, Fletterick, (1995) J. Mol. Biol., 247, pp. 251-259 
504 |a Rich, (1986) Proteinase Inhibitors, pp. 153-178. , A.J. Barrett, G. Salvenen, Elsevier, Amsterdam 
504 |a Brzin, Kopitar, Turk, Machleidt, (1983) Hoppe-Seyler's Z. Physiol. Chem., 364, pp. 1475-1480 
504 |a Pol, Olsson, Estrada, Prasthofer, Björk, Characterization by spectroscopic, kinetic and equilibrium methods of the interaction between recombinant human cystatin A (stefin A) and cysteine proteinases. (1995) Biochem J, , in press 
504 |a Jerala, Kroon-Žitko, Turk, (1994) Protein Purif., 5, pp. 65-69 
504 |a Lindahl, Alriksson, Jörnvall, Björk, (1988) Biochemistry, 27, pp. 5074-5082 
504 |a Cimerman, (1993) PhD Thesis, , University of Ljubljana 
504 |a Müller-Esterl, Johnson, Salvenen, Barrett, (1988) Methods Enzymol., 163, pp. 240-256 
504 |a Turk, Križaj, Kralj, Dolenc, Popoviè, Bieth, Turk, (1993) J. Biol. Chem., 268, pp. 7323-7329 
504 |a Gill, von Hippel, (1989) Anal. Biochem., 182, pp. 319-326 
504 |a Turk, Dolenc, Turk, Bieth, (1993) Biochemistry, 32, pp. 375-380 
504 |a Björk, Alriksson, Ylinenjärvi, (1989) Biochemistry, 28, pp. 1568-1573 
504 |a Turk, Čolic, Stoka, Turk, (1994) FEBS Lett., 339, pp. 155-159 
504 |a Martínez, Cazzulo, (1992) FEMS Microbiol. Lett., 95, pp. 225-230 
504 |a Turk, Dolenc, Žerovnik, Turk, Gubenšek, Turk, (1994) Biochemistry, 33, pp. 14800-14806 
504 |a Mbwara, Gumm, Shaw, Lonsdale-Eccles, (1992) Eur. J. Biochem., 204, pp. 371-379 
504 |a Osorio, Pico, Luaces, (1992) Parasitology, 105, pp. 207-210 
504 |a Rockett, Playfair, Ashall, Targett, Angliker, Shaw, (1990) FEBS Lett., 259, pp. 257-259 
520 3 |a Cruzipain, the major cysteine proteinase from Trypanosoma cruzi epimastigotes, purified to a sequentially pure form, exists in multiple forms with pI values between 3.7 and 5.1, and an apparent molecular mass of 41 kDa. The enzyme is stable between pH 4.5-9.5. Cruzipain was found to be rapidly and tightly inhibited by various protein inhibitors of the cystatin superfamily (kass = 1.7-79 × 106M-1s-1, Kd = 1.4-72 pM). These results suggest a possible defensive role for the host's cystatins after parasite infection, and may be of use for the design of new therapeutic drugs. © 1995.  |l eng 
536 |a Detalles de la financiación: SAREC 
536 |a Detalles de la financiación: 4212 
536 |a Detalles de la financiación: Ministry of Science and Technology of the People's Republic of China 
536 |a Detalles de la financiación: 32.0433/94 
536 |a Detalles de la financiación: Acknowledgements: We gratefully acknowledge Prof. Dr. Roger Pain and Dr. Boris Turk lbr their advice and critical reading of the manuscript, Dr. Iztok Dolenc for helpful suggestions and Dr. Anka Ritonja tbr N-terminal sequencing. Recombinant human cystatin C was kindly provided by Dr. Nina Cimerman (Krka Pharmaceuticals, Slovenia). This work was supported by grants from the Ministry of Science and Technology of the Republic of Slovenia, the Swedish Medical Council (project no. 4212), the Swedish Council for Forestry and Agricultural Research (project no. 32.0433/94), the Swedish Agency for Research Cooperation with Developing Countries (SAREC), and Fundaci6n An-torchas (Argentina). 
593 |a Department of Biochemistry and Molecular Biology, J. Stefan Institute, Jamova 39, 61111 Ljubljana, Slovenia 
593 |a Department of Veterinary Medical Chemistry, Swedish University of Agricultural Sciences, Uppsala Biomedical Center, Box 575, S-751 23 Uppsala, Sweden 
593 |a Instituto de Investigaciones Bioquímicas 'Luis F. Leloir', Fundación Campomar-CONICET, Facultad de Ciencias Exactas y Naturales, Antonio Machado 151, 1405 Buenos Aires, Argentina 
690 1 0 |a CRUZIPAIN 
690 1 0 |a CYSTATIN 
690 1 0 |a CYSTEINE PROTEINASE 
690 1 0 |a INHIBITION 
690 1 0 |a KINETICS 
690 1 0 |a TRYPANOSOMA CRUZI 
690 1 0 |a CRUZIPAIN 
690 1 0 |a CYSTATIN 
690 1 0 |a CYSTATIN C 
690 1 0 |a CYSTEINE PROTEINASE 
690 1 0 |a KININOGEN 
690 1 0 |a PROTEINASE INHIBITOR 
690 1 0 |a STEFIN A 
690 1 0 |a STEFIN B 
690 1 0 |a ARTICLE 
690 1 0 |a ENZYME INHIBITION 
690 1 0 |a ENZYME PURIFICATION 
690 1 0 |a ENZYME STRUCTURE 
690 1 0 |a PRIORITY JOURNAL 
690 1 0 |a TRYPANOSOMA CRUZI 
690 1 0 |a ANIMAL 
690 1 0 |a CHICKENS 
690 1 0 |a COMPARATIVE STUDY 
690 1 0 |a CYSTATINS 
690 1 0 |a CYSTEINE ENDOPEPTIDASES 
690 1 0 |a ELECTROPHORESIS, POLYACRYLAMIDE GEL 
690 1 0 |a HUMAN 
690 1 0 |a ISOELECTRIC FOCUSING 
690 1 0 |a KINETICS 
690 1 0 |a MOLECULAR WEIGHT 
690 1 0 |a RECOMBINANT PROTEINS 
690 1 0 |a SUPPORT, NON-U.S. GOV'T 
690 1 0 |a TRYPANOSOMA CRUZI 
650 1 7 |2 spines  |a PH 
700 1 |a Nycander, M. 
700 1 |a Lenarčič, B. 
700 1 |a Labriola, C. 
700 1 |a Cazzulo, J.J. 
700 1 |a Björk, I. 
700 1 |a Turk, V. 
773 0 |d 1995  |g v. 370  |h pp. 101-104  |k n. 1-2  |p FEBS Lett.  |x 00145793  |w (AR-BaUEN)CENRE-552  |t FEBS Letters 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029161123&doi=10.1016%2f0014-5793%2895%2900798-E&partnerID=40&md5=2e41b4b35610061a41d08fc059734540  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.1016/0014-5793(95)00798-E  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_00145793_v370_n1-2_p101_Stoka  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00145793_v370_n1-2_p101_Stoka  |y Registro en la Biblioteca Digital 
961 |a paper_00145793_v370_n1-2_p101_Stoka  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
963 |a VARI 
999 |c 73397